Log on / register
Feedback | Support | My details
Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report.
Sprinzl MF, Schimanski CC, Moehler M, Schadmand-Fischer S, Galle PR, Kanzler S
BMC Cancer 2006, 6:190
[Full text] [PubMed] [Related articles]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
EGFR expression in gallbladder carcinoma in North America.
Kaufman M, Mehrotra B, Limaye S, White S, Fuchs A, Lebowicz Y, Nissel-Horowitz S, Thomas A
Int J Med Sci 2008, 5:285-91
 [PubMed Central] [PubMed] [Related articles]
2.
EGFR and HER2 expression in advanced biliary tract cancer.
Harder J, Waiz O, Otto F, Geissler M, Olschewski M, Weinhold B, Blum HE, Schmitt-Graeff A, Opitz OG
World J Gastroenterol 2009 Sep 28, 15:4511-7
 [PubMed Central] [PubMed] [Related articles]
3.
Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma.
Sirica AE
World J Gastroenterol 2008 Dec 14, 14:7033-58
 [PubMed Central] [PubMed] [Related articles]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.